Where Success Begins

Science-led integrated drug discovery: medicinal and synthetic chemistry, computational chemistry, in vitro biosciences, DMPK, compound management and diversity and fragment libraries.

Read more

About Us

BioAscent is a leading provider of integrated drug discovery services

Founded in 2013, BioAscent is a leading provider of integrated drug discovery services based at the former Organon / MSD R&D site in Newhouse, Scotland, UK. Our drug discovery services include de novo assay development, target analysis and bespoke screening strategies, compound screening (including HTS), medicinal and synthetic chemistry, computational chemistry and compound management, all with access to in-house diversity and fragment libraries.

Read more

News

Highlights in Synthesis - Skeletal editing: a pioneering tool to accelerate drug discovery. Part 2: To swap or not to swap?

11 December 2024


Skeletal editing is a completely new paradigm in organic chemistry that allows for rapid modification of the core of a c...

Read more

From placement to permanent: BioAscent welcomes Rita Pereira to the biosciences team

10 December 2024


BioAscent is pleased to welcome Rita Pereira back to the company as a permanent member of the biosciences team, followin...

Read more

BioAscent's leading expertise in GPCR drug discovery drives customer success

26 November 2024


We never set out to become a specialist GPCR drug discovery company, nor do we see ourselves as one today. Our identity...

Read more

BioAscent awarded prestigious Knowledge Transfer Partnership with Centre for Targeted Protein Degradation at the University of Dundee

04 November 2024


New collaboration to develop innovative chemistry for more efficient protein degrader molecules.BioAscent is proud to an...

Read more

Integrated Drug Discovery


Science-led drug discovery

Get in Touch

Let's talk about how we can maximise your drug discovery success.

Contact